Exelixis
EXEL
#1731
Rank
HK$91.53 B
Marketcap
HK$341.41
Share price
-1.09%
Change (1 day)
20.53%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company